Back
Rhythm Pharmaceuticals Stock Price Chart
Sponsored
RYTM
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
83
RYTM
Rhythm Pharmaceuticals
Last Price:
56.20
Seasonality Move:
9.98%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
Rhythm Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.39 | Buy |
20-day SMA: | 49.93 | Buy |
50-day SMA: | 49.91 | Buy |
200-day SMA: | 44.75 | Buy |
8-day EMA: | 51.36 | Buy |
20-day EMA: | 50.41 | Buy |
50-day EMA: | 49.48 | Buy |
200-day EMA: | 44 | Buy |
Rhythm Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.59 | Buy |
Relative Strength Index (14 RSI): | 68.09 | Buy |
Chaikin Money Flow: | 665448 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.95 - 51.79) | Buy |
Bollinger Bands (100): | (44.14 - 51.3) | Buy |
Rhythm Pharmaceuticals Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Rhythm Pharmaceuticals Stock
Is Rhythm Pharmaceuticals Stock a Buy?
- Rhythm Pharmaceuticals share price is 56.25 while RYTM 8-day simple moving average is 50.39, which is a Buy signal.
- The stock price of RYTM is 56.25 while Rhythm Pharmaceuticals 20-day SMA is 49.93, which makes it a Buy.
- Rhythm Pharmaceuticals 50-day simple moving average is 49.91 while RYTM share price is 56.25, making it a Buy technically.
- RYTM stock price is 56.25 and Rhythm Pharmaceuticals 200-day simple moving average is 44.75, creating a Buy signal.
RYTM Technical Analysis vs Fundamental Analysis
Buy
83
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy or a Sell?
-
Rhythm Pharmaceuticals stock is rated a Buy
The current Rhythm Pharmaceuticals [RYTM] share price is $56.25. The Score for RYTM is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
Rhythm Pharmaceuticals Stock Info
Market Cap:
3.44B
Price in USD:
56.25
Share Volume:
792.21K
Rhythm Pharmaceuticals 52-Week Range
52-Week High:
56.58
52-Week Low:
23.83
Buy
83
Rhythm Pharmaceuticals (RYTM)
is a Buy
Rhythm Pharmaceuticals Share Price Forecast
-
What is the Rhythm Pharmaceuticals stock price today?
The Rhythm Pharmaceuticals stock price is 56.25 USD today. -
Will RYTM stock go up or go down?
Rhythm Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Rhythm Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rhythm Pharmaceuticals is not overvalued.
Is Rhythm Pharmaceuticals Stock a Buy?
- Rhythm Pharmaceuticals share price is 56.25 while RYTM 8-day exponential moving average is 51.36, which is a Buy signal.
- The stock price of RYTM is 56.25 while Rhythm Pharmaceuticals 20-day EMA is 50.41, which makes it a Buy.
- Rhythm Pharmaceuticals 50-day exponential moving average is 49.48 while RYTM share price is 56.25, making it a Buy technically.
- RYTM stock price is 56.25 and Rhythm Pharmaceuticals 200-day simple moving average is 44.00, creating a Buy signal.
Fundamental Analysis of Rhythm Pharmaceuticals
Is Rhythm Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.35 per share, and an increase next year of $1.61 per share.
Technical Analysis of Rhythm Pharmaceuticals
Should I short Rhythm Pharmaceuticals stock?
- RYTM Moving Average Covergence Divergence (MACD) indicator is 0.59, suggesting Rhythm Pharmaceuticals is a Buy
- Rhythm Pharmaceuticals Relative Strength Index (RSI) is 68.09, which suggest Rhythm Pharmaceuticals is overbought
- The Bollinger Bands (25) for Rhythm Pharmaceuticals is (47.95 - 51.79), which suggest Rhythm Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Rhythm Pharmaceuticals is (44.14 - 51.3), which suggest Rhythm Pharmaceuticals is a Buy
* Rhythm Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.